388 results on '"Van Krieken, J. Han"'
Search Results
2. A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma
3. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL
4. Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma Recurrences
5. Deep learning based tumor–stroma ratio scoring in colon cancer correlates with microscopic assessment
6. Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer.
7. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements
8. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
9. Lymphoproliferative Erkrankungen der Niere und ableitenden Harnwege
10. Lymphoproliferative Erkrankungen des weiblichen und männlichen Genitaltrakts sowie der Mamma
11. Diagnostische Strategien, Immunhistochemie und molekulare Diagnostik lymphatischer Gewebe
12. Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms
13. Correction to: Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements
14. Self-Supervised Learning Reveals Clinically Relevant Histomorphological Patterns for Therapeutic Strategies in Colon Cancer
15. External Quality Assessment Identifies Training Needs to Determine the Neoplastic Cell Content for Biomarker Testing
16. Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe
17. Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
18. Global Consultation on Cancer Staging: promoting consistent understanding and use
19. PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program
20. e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study
21. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria
22. Gastric Antrum (Distal Stomach)
23. Ménétrier’s Disease
24. Autoimmune Gastritis
25. Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma
26. Pathways towards indolent B-cell lymphoma — Etiology and therapeutic strategies
27. AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma
28. XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53
29. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
30. Gastric Cardia (Proximal Stomach)
31. Hemophagocytic Syndrome
32. Diagnostische Strategien, Immunhistochemie und molekulare Diagnostik lymphatischer Gewebe
33. Lymphoproliferative Erkrankungen der Niere und ableitenden Harnwege
34. Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
35. Consensus molecular subtype transition during progression of colorectal cancer
36. Supplementary Tables from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
37. Data from Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents
38. Data from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
39. Supplementary Tables 1-5 and Supplementary Figures 1-8 from Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents
40. EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
41. Supplementary Figures 1-3 from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
42. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
43. Small cell B-cell lymphoma
44. Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy
45. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1
46. Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions
47. Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma
48. Supplmentary Documents including Methods, Tables, and Legends for Supplementary Figures, and Supplementary Figure S1-S5 from Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma
49. Supplementary Figure from Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma
50. Supplementary Table 1 from T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.